One-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement for Stenotic Bicuspid versus Tricuspid Aortic Valves: A Meta-Analysis and Meta-Regression

Table 2

Short-term outcomes after TAVR for patients with bicuspid versus tricuspid (Reference) aortic valves.

Short-term outcome	Proportion of patients in the BAV group	Proportion of patients in the TAV group	Relative Risk or Standardized Mean Difference	Estimate	95 Confidence Interval	Heterogenicity; I^2()
Moderate-severe prosthetic valve regurgitation	61/559	80/1560	RR	1.54	1.07-2.22	0
Device success	624/721	2961/3169	RR	0.62	0.45-0.84	0
Composite Safety	11/49	113/531	RR	1.1	0.64-1.91	0
Mean Aortic Gradient	721	3169	SMD	0.03	-0.08-0.15	11.9
Acute Kidney Injury	18/683	165/1812	RR	0.24	0.059-2.25	18.4
Permanent Pacemaker Implantation	121/721	787/3169	RR	0.94	0.71-1.25	32.6

BAV = bicuspid aortic valve; TAV = tricuspid aortic valve; RR = Relative Risk; SMD = Standardized Mean Difference.